SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-24-014649
Filing Date
2024-04-15
Accepted
2024-04-15 17:01:47
Documents
54
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 999327
2 ex31-1.htm EX-31.1 17322
3 ex31-2.htm EX-31.2 17321
4 ex32-1.htm EX-32.1 8307
5 ex32-2.htm EX-32.2 8296
6 form10-q_001.jpg GRAPHIC 5599
  Complete submission text file 0001493152-24-014649.txt   4937708

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE orgs-20230331.xsd EX-101.SCH 32408
8 XBRL CALCULATION FILE orgs-20230331_cal.xml EX-101.CAL 57586
9 XBRL DEFINITION FILE orgs-20230331_def.xml EX-101.DEF 125199
10 XBRL LABEL FILE orgs-20230331_lab.xml EX-101.LAB 289448
11 XBRL PRESENTATION FILE orgs-20230331_pre.xml EX-101.PRE 216595
57 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 729738
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-38416 | Film No.: 24845333
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)